_id

69109443ccc777a4e85d5a82

Ticker

EDSA

Name

Edesa Biotech Inc

Exchange

NASDAQ

Address

100 Spy Court, Markham, ON, Canada, L3R 5H6

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.edesabiotech.com

Description

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Last Close

1.75

Volume

12832

Current Price

1.74

Change

-0.571428571428572

Last Updated

2025-11-29T12:34:07.820Z

Image

data:image/webp;base64,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

Ipo Date

2015-11-05T00:00:00.000Z

Market Cap

12847984

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

5

Target Price

11

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-06-30

Revenue

0

Cost Of Revenue

25787

Gross Profit

-25787

Operating Expenses

1903743

Operating Income

-1903743

Interest Expense

-

Pretax Income

-1749464

Net Income

-1749464

Eps

-0.24911636273227963

Dividends Per Share

-

Shares Outstanding

7341705

Income Tax Expense

-

EBITDA

-1694675

Operating Margin

-

Total Other Income Expense Net

154279

Cash

12361690

Short Term Investments

-

Receivables

286743

Inventories

-

Total Current Assets

12761092

Property Plant Equipment

0

Total Assets

14804800

Payables

-

Short Term Debt

-

Long Term Debt

-

Total Liabilities

672674

Equity

14132126

Depreciation

25787

Change In Working Capital

-178897

Cash From Operations

-1750998

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

216924

Net Change In Cash

-1534960

PE

-

PB

0.8646582771764136

ROE

-12.379340518192379

ROA

-11.816870204258079

FCF

-1750998

Fcf Percent

-

Piotroski FScore

0

Health Score

41

Deep Value Investing Score

6.5

Defensive Investing Score

5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

4.5

Quality Investing Score

3

Value Investing Score

5.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

25787

Quarters > 0 > income Statement > gross Profit

-25787

Quarters > 0 > income Statement > operating Expenses

1903743

Quarters > 0 > income Statement > operating Income

-1903743

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1749464

Quarters > 0 > income Statement > net Income

-1749464

Quarters > 0 > income Statement > eps

-0.24911636273227963

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

7022678

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1694675

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

154279

Quarters > 0 > balance Sheet > cash

12361690

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

286743

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

12761092

Quarters > 0 > balance Sheet > property Plant Equipment

0

Quarters > 0 > balance Sheet > total Assets

14804800

Quarters > 0 > balance Sheet > payables

-

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

672674

Quarters > 0 > balance Sheet > equity

14132126

Quarters > 0 > cash Flow > net Income

-1749464

Quarters > 0 > cash Flow > depreciation

25787

Quarters > 0 > cash Flow > change In Working Capital

-178897

Quarters > 0 > cash Flow > cash From Operations

-1750998

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

216924

Quarters > 0 > cash Flow > net Change In Cash

-1534960

Quarters > 0 > ratios > PE

-0.24911636273227963

Quarters > 0 > ratios > PB

0.8646582771764136

Quarters > 0 > ratios > ROE

-12.379340518192379

Quarters > 0 > ratios > ROA

-11.816870204258079

Quarters > 0 > ratios > FCF

-1750998

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

41

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

24509

Quarters > 1 > income Statement > gross Profit

-24509

Quarters > 1 > income Statement > operating Expenses

1638886

Quarters > 1 > income Statement > operating Income

-1638886

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-1589648

Quarters > 1 > income Statement > net Income

-1590448

Quarters > 1 > income Statement > eps

-0.2997585832612576

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

5305763

Quarters > 1 > income Statement > income Tax Expense

800

Quarters > 1 > income Statement > EBITDA

-1565144

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

49238

Quarters > 1 > balance Sheet > cash

13896650

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

382440

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

14387289

Quarters > 1 > balance Sheet > property Plant Equipment

0

Quarters > 1 > balance Sheet > total Assets

16454299

Quarters > 1 > balance Sheet > payables

914701

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

914701

Quarters > 1 > balance Sheet > equity

15539598

Quarters > 1 > cash Flow > net Income

-1590448

Quarters > 1 > cash Flow > depreciation

24509

Quarters > 1 > cash Flow > change In Working Capital

-872315

Quarters > 1 > cash Flow > cash From Operations

-2333067

Quarters > 1 > cash Flow > capital Expenditures

2.86

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

14772870

Quarters > 1 > cash Flow > net Change In Cash

12333148

Quarters > 1 > ratios > PE

-0.2997585832612576

Quarters > 1 > ratios > PB

0.5940969399594507

Quarters > 1 > ratios > ROE

-10.234807875982376

Quarters > 1 > ratios > ROA

-9.665850851500874

Quarters > 1 > ratios > FCF

-2333069.86

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

41

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

43109

Quarters > 2 > income Statement > gross Profit

-43109

Quarters > 2 > income Statement > operating Expenses

1898689

Quarters > 2 > income Statement > operating Income

-1898689

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-1617253

Quarters > 2 > income Statement > net Income

-1617253

Quarters > 2 > income Statement > eps

-0.4834641950175404

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

3345135

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1574149

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

281436

Quarters > 2 > balance Sheet > cash

1563502

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

350639

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

2071928

Quarters > 2 > balance Sheet > property Plant Equipment

0

Quarters > 2 > balance Sheet > total Assets

4164181

Quarters > 2 > balance Sheet > payables

1900219

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1900219

Quarters > 2 > balance Sheet > equity

2263962

Quarters > 2 > cash Flow > net Income

-1617253

Quarters > 2 > cash Flow > depreciation

43109

Quarters > 2 > cash Flow > change In Working Capital

-24242

Quarters > 2 > cash Flow > cash From Operations

-1517203

Quarters > 2 > cash Flow > capital Expenditures

3

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

2071545

Quarters > 2 > cash Flow > net Change In Cash

526182

Quarters > 2 > ratios > PE

-0.4834641950175404

Quarters > 2 > ratios > PB

2.5709507933437044

Quarters > 2 > ratios > ROE

-71.43463538698971

Quarters > 2 > ratios > ROA

-38.837240744338445

Quarters > 2 > ratios > FCF

-1517206

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

1004396

Quarters > 3 > income Statement > operating Income

-1004396

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-962051

Quarters > 3 > income Statement > net Income

-962051

Quarters > 3 > income Statement > eps

-0.300883242536255

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

3197423

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-917844

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

42345

Quarters > 3 > balance Sheet > cash

1037320

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

270908

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1675622

Quarters > 3 > balance Sheet > property Plant Equipment

18361

Quarters > 3 > balance Sheet > total Assets

3813982

Quarters > 3 > balance Sheet > payables

1812960

Quarters > 3 > balance Sheet > short Term Debt

19867

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1832827

Quarters > 3 > balance Sheet > equity

1981155

Quarters > 3 > cash Flow > net Income

-962051

Quarters > 3 > cash Flow > depreciation

44206

Quarters > 3 > cash Flow > change In Working Capital

-143127

Quarters > 3 > cash Flow > cash From Operations

-967039

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-31435

Quarters > 3 > cash Flow > net Change In Cash

-1003564

Quarters > 3 > ratios > PE

-0.300883242536255

Quarters > 3 > ratios > PB

2.808218448329384

Quarters > 3 > ratios > ROE

-48.56010761399285

Quarters > 3 > ratios > ROA

-25.224319359661372

Quarters > 3 > ratios > FCF

-967039

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

38

Valuation > metrics > PE

-0.24911636273227963

Valuation > metrics > PB

0.8646582771764136

Valuation > final Score

70

Valuation > verdict

13.5% Undervalued

Profitability > metrics > ROE

-12.379340518192379

Profitability > metrics > ROA

-13.70935966921953

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.047598924606248205

Risk > metrics > Interest Coverage

-34.746810491156985

Risk > final Score

-79

Risk > verdict

High

Liquidity > final Score

50

Liquidity > verdict

Weak

Prev Valuations > 0

70

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-208

Prev Risks > 1

-128

Prev Risks > 2

-43

Prev Liquidities > 0

100

Prev Liquidities > 1

77

Prev Liquidities > 2

56

Updated At

2025-12-13T00:36:32.757Z